Country factsheets

Liechtenstein

Liechtenstein

Download data
6 May 2022

Date of search

6 May 2022

Certificate adoption

There is presently no indication that Liechtenstein has adopted COVID-19 certification.

  • No issuance of vaccination certificates
  • No issuance of recovery certificates
  • No issuance of negative test certificates
  • No issuance of verification certificates

Entry protocol

For general measure

    • Currently, travellers are allowed to enter Liechtenstein without vaccination, recovery or test certificate requirements.

Vaccine authorised to be used in the country

  • Pfizer/BioNTech
  • Moderna
  • Curevac (Unofficial)
  • AstraZeneca
  • Novavax (Unofficial)

Vaccine accepted for inbound travellers

  • Comirnaty Pfizer/BioNTech by BioNTech Manufacturing GmbH
  • Spikevax, formerly Moderna by Moderna Biotech Spain, SL
  • Vaxzevria, formerly AstraZeneca by AstraZeneca Ab
  • Janssen (Johnson & Johnson) by Janssen – Cilag International NV
  • BIBP/Sinopharm by Beijing Institute of Biological Products
  • Covishield by Serum Institute of India
  • CoronaVac by Sinovac Life Sciences

Border status

Open

Remarks

Liechtenstein’s immigration and customs affairs are handled by Switzerland. The requirements for entry are the same as for Switzerland. Switzerland and Liechtenstein share an open border.

6 th Floor, 6 th Building, Department of Health, Ministry of Public Health, Tiwanon Rd., Muang, Nonthaburi 11000, Thailand

WORKING GROUP MEMBERS

SUPPORTED BY

© Copyright © 2002-2021 HITAP. All rights reserved. This information—including product information—is intended only for residents of Thailand.